Clinical trial
Perspective Randomized Study Aimed at Evaluating the Effectiveness of the EmoLED Medical Device in the Treatment of Second and Third Stage Pressure Ulcers
NCT05130814 is registered in ClinicalTrials.gov with Emoled as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Perspective Randomized Study Aimed at Evaluating the Effectiveness of the EmoLED Medical Device in the Treatment of Second and Third Stage Pressure Ulcers
- Lead sponsor
- Emoled
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- December 1, 2021
- Completion date
- March 7, 2024
- Enrollment
- 48 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
pressure sore, pressure ulcer, pressure ulcers stage ii, pressure ulcers stage iii